Testing Aconite Pain Oil for Chemotherapy Nerve Damage
Part of Cancer, Pain clinical trials.
This trial tests a pain oil made from aconite (a plant extract) to see if it can prevent or reduce nerve damage and pain caused by chemotherapy. It is for people with solid tumors who are starting treatment with taxane or platinum drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and have a solid tumor cancer like breast, lung, or colon cancer.
- You should be about to start chemotherapy with a taxane (like paclitaxel) or platinum (like carboplatin) drug, or both, for at least 3 months.
- You must not have had nerve damage (polyneuropathy) in the past, from any cause.
- You need to be able to care for yourself (Karnofsky score of 70% or higher) and have a life expectancy of at least 12 months.
- You should not be using certain pain medications or creams on your hands/feet before the trial starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using essential oils can help reduce pain, tingling, or numbness in hands and feet caused by paclitaxel chemotherapy for breast cancer. If regular pain medications aren't working well, this natural approach may offer additional relief.
This trial tests if wearing cold gloves and socks during chemo can prevent nerve damage in hands and feet. It is for women with breast or genital cancer getting a taxane chemo drug for the first time.
This trial tests whether a blend of CBG and CBD oils can help relieve nerve pain, tingling, or weakness caused by platinum-based chemotherapy in people with certain gastrointestinal cancers. If you have had colorectal, biliary, pancreatic, esophageal, gastric, or small intestinal cancer and completed chemo in the last 2 years, you may be able to join.
This trial tests whether acupuncture and compression therapy can prevent nerve damage caused by taxane chemotherapy in early-stage breast cancer. It aims to reduce numbness, tingling, or pain in the hands and feet.
This trial tests whether a cannabis-based product can reduce nerve damage (neuropathy) caused by chemotherapy in people who have finished treatment for breast or colon cancer. It focuses on survivors who still have pain, numbness, or tingling in their hands or feet.
This trial tests if adding electroacupuncture, a gentle type of acupuncture using mild electric pulses, can help relieve nerve pain, tingling, or numbness caused by chemotherapy in people with cancer.
Hear when a new Chemotherapy-induced Polyneuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.